ASN opposes proposed $1.6 billion reduction to NIH budget

NewsGuard 100/100 Score

Proposed cuts to the National Institutes of Health (NIH) budget for 2011 will limit the nation's ability to advance patient care and public health.

Position: The American Society of Nephrology (ASN) strongly opposes the proposed $1.6 billion reduction to the NIH budget included in the continuing resolution (fiscal year 2011) being debated in the House of Representatives. The nation's longstanding commitment to better health has established the United States as a world leader in medical research and innovation. This leading position will be endangered should the 5.2 percent decrease in the NIH budget be implemented.

"This funding is crucial to NIH in order to advance scientific research, promote innovation, encourage new generations of investigators to pursue research vital to improving health, and preserve and create jobs," explains Joseph V. Bonventre, MD, PhD, ASN President (Brigham and Women's Hospital, Boston, MA). "This is no time to limit medical advances made through NIH funded research."

ASN strongly values funding for NIH research, which supports:
1. Improved patient care: Research funded by NIH is critical to improved treatment of disease, including kidney disease, which afflicts 1 in 9 Americans.
2. Economic recovery: More than 83 percent of NIH funding is spent in communities across the nation, creating jobs at more than 3,000 universities, medical schools, teaching hospitals, and other research institutions nationwide.
3. Long-term competitiveness: NIH funding forms one of the key foundations for long-term US global competitiveness in industries such as biotechnology, medical devices, pharmaceuticals, and in academics.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis